Next Article in Journal
In Vitro Toxicological Assessment of Cylindrospermopsin: A Review
Next Article in Special Issue
Correction of Malocclusion by Botulinum Neurotoxin Injection into Masticatory Muscles
Previous Article in Journal
Expression of Staphylococcal Enterotoxins under Stress Encountered during Food Production and Preservation
Previous Article in Special Issue
Botulinum Toxin in Management of Limb Tremor
 
 
Review

Botulinum Toxin in the Field of Dermatology: Novel Indications

Department of Dermatology, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea
*
Author to whom correspondence should be addressed.
Academic Editor: Siro Luvisetto
Toxins 2017, 9(12), 403; https://doi.org/10.3390/toxins9120403
Received: 20 November 2017 / Revised: 13 December 2017 / Accepted: 14 December 2017 / Published: 16 December 2017
Since its approval by the US Food and Drug Administration in 2002 for glabellar wrinkles, botulinum toxin (BTX) has been widely used to correct facial wrinkles. As a result, many consider BTX synonymous with cosmetic dermatology. Recent studies indicate that BTX elicits biological effects on various skin cell types via the modulation of neurotransmitter release, and it seems that BTX has a wider zone of dermatologic influence than originally understood. Clinicians and researchers are now beginning to explore the potential of BTX beyond the amelioration of facial lines and encouraging results are seen with BTX in a variety of skin conditions. In this paper, we review novel dermatological indications of BTX which includes (but not limited to) scar prevention, facial flushing, post-herpetic neuralgia and itch. These areas show great promise, but there is definite need for larger, double-blinded, randomized control trials against established treatments before BTX becomes a clinical reality. View Full-Text
Keywords: botulinum toxin; biological effect; various cell types; neurotransmitter; dermatology; novel indication botulinum toxin; biological effect; various cell types; neurotransmitter; dermatology; novel indication
MDPI and ACS Style

Kim, Y.S.; Hong, E.S.; Kim, H.S. Botulinum Toxin in the Field of Dermatology: Novel Indications. Toxins 2017, 9, 403. https://doi.org/10.3390/toxins9120403

AMA Style

Kim YS, Hong ES, Kim HS. Botulinum Toxin in the Field of Dermatology: Novel Indications. Toxins. 2017; 9(12):403. https://doi.org/10.3390/toxins9120403

Chicago/Turabian Style

Kim, Yoon Seob, Eun Sun Hong, and Hei Sung Kim. 2017. "Botulinum Toxin in the Field of Dermatology: Novel Indications" Toxins 9, no. 12: 403. https://doi.org/10.3390/toxins9120403

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop